Human biomonitoring and environmental health
6 European H2020 organizations list this as part of their work.
Most active in this area
- INSTITUTO DE SALUD CARLOS III
Spain's national health research institute and funding agency, coordinating transnational ERA-NET calls across biomedical and public health domains.
“Participated in HBM4EU (their largest single grant at EUR 3.4M) and ICARUS (urban air pollution), indicating growing engagement in exposure science and population health monitoring.”
ES53 projects - LUXEMBOURG INSTITUTE OF HEALTH
Luxembourg biomedical research institute specializing in biomarker discovery, cancer immunoprofiling, and translational diagnostics across major disease areas.
“HBM4EU (European biomonitoring initiative covering chemical exposures) and early-period focus on exposure biomarkers and endocrine disruptors.”
LU24 projects - UMWELTBUNDESAMT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (UBA GMBH)
Austria's national environment agency providing ecosystem monitoring, soil and land-use expertise, environmental data infrastructure, and science-to-policy translation across Europe.
“Received their largest single grant (EUR 1.24M) in HBM4EU, indicating deep in-house capacity for chemical exposure and biomarker analysis.”
AT23 projects - MINISTRY OF HEALTH
Israel's national health authority coordinating transnational research funding in rare diseases, AMR, neuroscience, and personalized medicine through ERA-NET mechanisms.
“Contributed to HBM4EU (European Human Biomonitoring Initiative) and AquaticPollutants, covering exposure biomarkers, endocrine disruptors, and waterborne health risks.”
IL22 projects - RIGAS STRADINA UNIVERSITATE
Latvia's leading medical university specializing in infectious disease diagnostics, biomaterials, and translational medicine across European health consortia.
“HBM4EU involved RSU in European-scale biomonitoring for exposure biomarkers, endocrine disruptors, and chemical mixtures in human cohorts.”
LV13 projects - UNIVERZITETNI KLINICNI CENTER LJUBLJANA
Slovenia's largest university hospital contributing clinical cohorts, patient data, and translational expertise to European infectious disease, rare disease, and precision medicine research.
“Contributed to HBM4EU, the flagship European biomonitoring initiative tracking chemical exposure biomarkers and endocrine disruptors across population cohorts.”
SI10 projects